Loading clinical trials...
Loading clinical trials...
An Open-Label Study Study of Sipuleucel-T in European Men With Metastatic, Castrate Resistant Prostate Cancer
Conditions
Interventions
sipuleucel-T
Locations
4
Austria
Ludwig Boltzmann-Institute for Applied Cancer Research
Vienna, Austria
Department of Cancer Medicine and Genitourinary Oncology Group Institut Gustave Roussy (IGR) Département de médicine
Vaillant, Villejuif Cedex, France
Radboud University Nijmegen; UMC St Radboud Hospital; Faculteit der Medische Wetenschappen, Urologie
Nijmegen, Gelderland, Netherlands
Barts Cancer Institute - a Cancer Research UK Centre of Excellence, Queen Mary University of London
London, United Kingdom
Start Date
June 1, 2012
Primary Completion Date
June 1, 2014
Completion Date
June 1, 2014
Last Updated
December 9, 2015
NCT04633252
NCT07072728
NCT03354416
NCT04887935
NCT05600400
NCT07109427
Lead Sponsor
Dendreon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions